GlassScriptPhysician profile
Omesh Singh
NPI 1912254145
$4,955.04
in general payments reported to CMS, 2019-2025
39 companies · $591 in 2025
The $591 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $196 · 2021: $917 · 2022: $948 · 2023: $776 · 2024: $759 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,215.95 | 2021-2024 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $523.00 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $478.45 | 2019-2024 | Repatha, Otezla |
| Coloplast Corp | $400.23 | 2021-2022 | |
| Lilly USA, LLC | $271.74 | 2019-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $264.48 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $211.64 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $166.49 | 2019-2025 | |
| Abbott Laboratories | $143.70 | 2021-2024 | Freestyle Libre 2, Jot Dx |
| Ipsen Biopharmaceuticals, INC | $143.64 | 2025 | Dysport |
| Medtronic, INC. | $128.22 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $105.10 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $99.05 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $85.50 | 2023-2024 | Veozah, Myrbetriq |
| Stimwave Technologies Incorporated | $68.49 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omesh Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.